Merck & Company Inc (MRK) Stock Forecast & Price Target
Merck & Company Inc · NYSE
$143.93-0.79 (-0.54%)
15-min delayed · Sep 11, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 21 firms covering Merck & Company Inc, 14 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $90.00 to $180.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $146.65 sits 2% above the current $143.93. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 12 to 14 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.95 next quarter toward $9.55 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS21 ratings
Moderate Buy
Strong Buy00%
Buy1467%
Hold733%
Sell00%
Strong Sell00%
Based on 21 analysts giving stock ratings to Merck & Company Inc.
As of Sep, 14 of 20 firms rate MRK a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MRK EPS & revenue forecast
EPS · NEXT QUARTER
$1.95
Range $1.86 – $2.09 · 17 analysts · -4% YoY
Next period, 17 analysts expect Merck & Company Inc to earn $1.95 a share (range $1.86 – $2.09), versus $2.04 a year earlier. Full-year consensus is $2.75, growing to $9.55 the year after.
REVENUE · NEXT QUARTER
$16.9B
Range $16.3B – $17.1B · 17 analysts · +3% YoY
Revenue is expected to reach $16.9B (range $16.3B – $17.1B), +2.9% year-over-year. Full-year consensus is $67.2B, rising to $70.3B next year.
Top analysts covering Merck & Company Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MRK.
#1
Vamil Divan
Guggenheim · Rank #109
Buy
$146.00+1.4% to target
Overall win rate
48%
+ Follow
#2
Jason Gerberry
B of A Securities · Rank #130
Buy
$166.00+15.3% to target
Overall win rate
46%
+ Follow
#3
Daina Graybosch
Leerink Partners · Rank #309
Buy
$114.00-20.8% to target
Overall win rate
40%
+ Follow
#4
Mohit Bansal
Wells Fargo
Buy
$170.00+18.1% to target
Coverage
—
+ Follow
#5
Terence Flynn
Morgan Stanley
Buy
$179.00+24.4% to target
Coverage
—
+ Follow
MRK stock forecast FAQ
What is MRK's average 12-month price target?+
The 19 analysts with a live target average $146.65 for Merck & Company Inc over the next 12 months, ranging from a $180.00 high to a $90.00 low.
Is MRK stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 21 analyst ratings, 14 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MRK?+
The Street-high target is $180.00 (Wolfe Research), and the Street-low is $90.00 (Berenberg). The average of all 19 active targets is $146.65.
How many Wall Street analysts cover MRK?+
21 analysts have an active rating on Merck & Company Inc, and 19 firms carry a live 12-month price target.
Who is the most accurate analyst covering MRK?+
Among analysts who currently cover MRK, Vamil Divan of Guggenheim has the strongest overall Quantellect track record (Rank #109). Their current call is Buy with a $146.00 target.
What is Merck & Company Inc's projected EPS for next quarter?+
The consensus estimate is $1.95 per share (range $1.86 – $2.09) across 17 analysts. Full-year EPS is projected at $2.75, rising to $9.55 the following year.
How much revenue is Merck & Company Inc expected to report next quarter?+
Consensus revenue is $16.9B (range $16.3B – $17.1B). Full-year revenue is projected at $67.2B, growing to $70.3B next year.
Have analysts been upgrading or downgrading MRK lately?+
As of Sep, 14 of 20 firms rate MRK a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MRK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
